Annual ROA
-75.53%
-26.69%-54.65%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual return on assets is currently -75.53%, with the most recent change of -26.69% (-54.65%) on 31 December 2023. During the last 3 years, it has fallen by -24.13% (-46.95%). TNXP annual ROA is now -97.15% below its all-time high of -38.31%, reached on 31 December 2021.TNXP ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-113.77%
+5.59%+4.68%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly return on assets is currently -113.77%, with the most recent change of +5.59% (+4.68%) on 30 September 2024. Over the past year, it has dropped by -44.99% (-65.41%). TNXP quarterly ROA is now -178.37% below its all-time high of -40.87%, reached on 30 June 2022.TNXP Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -54.6% | -65.4% |
3 y3 years | -47.0% | -144.5% |
5 y5 years | +23.8% | +23.9% |
TNXP ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -97.2% | at low | -178.4% | +4.7% |
5 y | 5 years | -97.2% | +61.6% | -178.4% | +38.5% |
alltime | all time | -97.2% | +92.9% | -178.4% | +98.1% |
Tonix Pharmaceuticals Holding ROA History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -113.77%(-4.7%) |
June 2024 | - | -119.36%(+78.2%) |
Mar 2024 | - | -66.98%(-9.2%) |
Dec 2023 | -75.53%(+54.6%) | -73.77%(+7.3%) |
Sept 2023 | - | -68.78%(+13.7%) |
June 2023 | - | -60.47%(+19.5%) |
Mar 2023 | - | -50.59%(+11.1%) |
Dec 2022 | -48.84%(+27.5%) | -45.53%(+3.5%) |
Sept 2022 | - | -43.97%(+7.6%) |
June 2022 | - | -40.87%(-9.5%) |
Mar 2022 | - | -45.16%(+1.3%) |
Dec 2021 | -38.31%(-25.5%) | -44.56%(-4.2%) |
Sept 2021 | - | -46.53%(-14.5%) |
June 2021 | - | -54.39%(-13.2%) |
Mar 2021 | - | -62.64%(-19.9%) |
Dec 2020 | -51.40%(-73.9%) | -78.21%(-19.1%) |
Sept 2020 | - | -96.64%(-24.3%) |
June 2020 | - | -127.61%(-18.5%) |
Mar 2020 | - | -156.57%(-15.4%) |
Dec 2019 | -196.58%(+98.3%) | -185.05%(+23.9%) |
Sept 2019 | - | -149.41%(+15.0%) |
June 2019 | - | -129.92%(+3.3%) |
Mar 2019 | - | -125.75%(-1.5%) |
Dec 2018 | -99.13%(+25.6%) | -127.72%(+9.3%) |
Sept 2018 | - | -116.84%(+16.1%) |
June 2018 | - | -100.60%(+24.8%) |
Mar 2018 | - | -80.62%(+11.5%) |
Dec 2017 | -78.95%(-44.1%) | -72.28%(-8.0%) |
Sept 2017 | - | -78.58%(-7.8%) |
June 2017 | - | -85.20%(-17.9%) |
Mar 2017 | - | -103.73%(-17.9%) |
Dec 2016 | -141.19% | -126.34%(+0.6%) |
Sept 2016 | - | -125.54%(+6.2%) |
Date | Annual | Quarterly |
---|---|---|
June 2016 | - | -118.22%(+5.6%) |
Mar 2016 | - | -111.91%(+25.9%) |
Dec 2015 | -102.20%(+46.3%) | -88.89%(+6.2%) |
Sept 2015 | - | -83.70%(+9.6%) |
June 2015 | - | -76.37%(+14.3%) |
Mar 2015 | - | -66.80%(+10.1%) |
Dec 2014 | -69.84%(-43.9%) | -60.65%(+2.7%) |
Sept 2014 | - | -59.03%(-8.6%) |
June 2014 | - | -64.55%(-23.2%) |
Mar 2014 | - | -84.08%(-66.8%) |
Dec 2013 | -124.59%(-72.1%) | -252.90%(-31.7%) |
Sept 2013 | - | -370.21%(-64.8%) |
June 2013 | - | -1050.82%(+23.3%) |
Mar 2013 | - | -852.55%(+46.2%) |
Dec 2012 | -446.39%(-45.3%) | -583.20%(-16.9%) |
Sept 2012 | - | -702.05%(+5.0%) |
June 2012 | - | -668.63%(+3.4%) |
Mar 2012 | - | -646.68%(-71.7%) |
Dec 2011 | -815.73%(-23.6%) | -2284.59%(-62.1%) |
Sept 2011 | - | -6031.56%(+59.5%) |
June 2011 | - | -3782.12%(+26.7%) |
Mar 2011 | - | -2985.54%(-24.5%) |
Dec 2010 | -1067.66%(+349.2%) | -3954.71%(+1678.4%) |
Sept 2010 | - | -222.38%(+52.0%) |
June 2010 | - | -146.29%(-24.7%) |
Mar 2010 | - | -194.35%(+23.6%) |
Dec 2009 | -237.69%(+417.1%) | -157.25%(+43.7%) |
Sept 2009 | - | -109.42%(+17.0%) |
June 2009 | - | -93.56%(+41.3%) |
Mar 2009 | - | -66.23%(-12.2%) |
Dec 2008 | -45.97% | -75.42%(-7.8%) |
Sept 2008 | - | -81.82%(-23.0%) |
June 2008 | - | -106.32%(-40.9%) |
Mar 2008 | - | -180.00% |
FAQ
- What is Tonix Pharmaceuticals Holding annual return on assets?
- What is the all time high annual ROA for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual ROA year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly return on assets?
- What is the all time high quarterly ROA for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly ROA year-on-year change?
What is Tonix Pharmaceuticals Holding annual return on assets?
The current annual ROA of TNXP is -75.53%
What is the all time high annual ROA for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual return on assets is -38.31%
What is Tonix Pharmaceuticals Holding annual ROA year-on-year change?
Over the past year, TNXP annual return on assets has changed by -26.69% (-54.65%)
What is Tonix Pharmaceuticals Holding quarterly return on assets?
The current quarterly ROA of TNXP is -113.77%
What is the all time high quarterly ROA for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly return on assets is -40.87%
What is Tonix Pharmaceuticals Holding quarterly ROA year-on-year change?
Over the past year, TNXP quarterly return on assets has changed by -44.99% (-65.41%)